Trending NewsTrending NewsNASDAQ:CVRX CVRx (CVRX) Stock Price, News & Analysis $7.24 +0.30 (+4.32%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$7.24 +0.00 (+0.07%) As of 08/8/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About CVRx Stock (NASDAQ:CVRX) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get CVRx alerts:Sign Up Key Stats Today's Range$6.88▼$7.3650-Day Range$5.66▼$8.6052-Week Range$4.30▼$18.55Volume280,251 shsAverage Volume355,268 shsMarket Capitalization$189.33 millionP/E RatioN/ADividend YieldN/APrice Target$14.00Consensus RatingModerate Buy Company Overview CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. The company offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure with reduced ejection fraction or systolic heart failure. It sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, and internationally. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota. Read More CVRx Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks58th Percentile Overall ScoreCVRX MarketRank™: CVRx scored higher than 58% of companies evaluated by MarketBeat, and ranked 419th out of 925 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.4 / 5Analyst RatingModerate Buy Consensus RatingCVRx has received a consensus rating of Moderate Buy. The company's average rating score is 2.86, and is based on 5 buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoverageCVRx has only been the subject of 2 research reports in the past 90 days.Read more about CVRx's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for CVRx are expected to grow in the coming year, from ($1.91) to ($1.63) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of CVRx is -3.45, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of CVRx is -3.45, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioCVRx has a P/B Ratio of 3.26. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted11.55% of the float of CVRx has been sold short.Short Interest Ratio / Days to CoverCVRx has a short interest ratio ("days to cover") of 5.3.Change versus previous monthShort interest in CVRx has recently increased by 0.56%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldCVRx does not currently pay a dividend.Dividend GrowthCVRx does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted11.55% of the float of CVRx has been sold short.Short Interest Ratio / Days to CoverCVRx has a short interest ratio ("days to cover") of 5.3.Change versus previous monthShort interest in CVRx has recently increased by 0.56%, indicating that investor sentiment is decreasing. News and Social Media2.8 / 5News Sentiment0.12 News SentimentCVRx has a news sentiment score of 0.12. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.50 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 26 news articles for CVRx this week, compared to 3 articles on an average week.Search Interest4 people have searched for CVRX on MarketBeat in the last 30 days. MarketBeat Follows1 people have added CVRx to their MarketBeat watchlist in the last 30 days. Company Ownership4.2 / 5Insider TradingAcquiring Shares Insider Buying vs. Insider SellingIn the past three months, CVRx insiders have bought more of their company's stock than they have sold. Specifically, they have bought $411,031.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders13.90% of the stock of CVRx is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions75.27% of the stock of CVRx is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about CVRx's insider trading history. Receive CVRX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for CVRx and its competitors with MarketBeat's FREE daily newsletter. Email Address CVRX Stock News HeadlinesCantor Fitzgerald Has Weak Forecast for CVRx FY2025 EarningsAugust 9 at 3:37 AM | americanbankingnews.comBrokers Issue Forecasts for CVRx's Q3 Earnings (NASDAQ:CVRX)August 9 at 2:53 AM | americanbankingnews.com$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could be the biggest technology story of this decade. In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom… And only one company here in the U.S. can mine this obscure metal.August 9 at 2:00 AM | Brownstone Research (Ad)Earnings Update: CVRx, Inc. (NASDAQ:CVRX) Just Reported Its Second-Quarter Results And Analysts Are Updating Their ForecastsAugust 8 at 10:11 AM | finance.yahoo.comCVRx's (CVRX) "Overweight" Rating Reaffirmed at Cantor FitzgeraldAugust 8 at 2:55 AM | americanbankingnews.comCVRx Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS LagsAugust 6 at 7:28 PM | finance.yahoo.comCVRx sees Q3 revenue $13.7M-$14.7M, consensus $14.54MAugust 6 at 5:02 AM | msn.comCVRx narrows FY25 revenue view to $55M-$57M from $55M-$58M, consensus $56.15MAugust 6 at 5:02 AM | msn.comSee More Headlines CVRX Stock Analysis - Frequently Asked Questions How have CVRX shares performed this year? CVRx's stock was trading at $12.67 at the beginning of 2025. Since then, CVRX shares have decreased by 42.9% and is now trading at $7.24. How were CVRx's earnings last quarter? CVRx, Inc. (NASDAQ:CVRX) posted its quarterly earnings data on Monday, August, 4th. The company reported ($0.57) EPS for the quarter, missing the consensus estimate of ($0.52) by $0.05. The business had revenue of $13.59 million for the quarter, compared to analyst estimates of $13.22 million. CVRx had a negative net margin of 95.61% and a negative trailing twelve-month return on equity of 79.31%. Read the conference call transcript. When did CVRx IPO? CVRx (CVRX) raised $100 million in an initial public offering on Wednesday, June 30th 2021. The company issued 6,250,000 shares at a price of $15.00-$17.00 per share. Who are CVRx's major shareholders? CVRx's top institutional shareholders include Geode Capital Management LLC (1.47%), Corton Capital Inc. (0.11%), Mitsubishi UFJ Asset Management Co. Ltd. (0.11%) and AlphaQuest LLC (0.05%). Insiders that own company stock include & Johnson Johnson, Kirk G Nielsen, Kevin Hykes, Joseph P Slattery, Mudit K Jain and Paul Verrastro. View institutional ownership trends. How do I buy shares of CVRx? Shares of CVRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of CVRx own? Based on aggregate information from My MarketBeat watchlists, some other companies that CVRx investors own include Tesla (TSLA), Advanced Micro Devices (AMD), JPMorgan Chase & Co. (JPM), Meta Platforms (META), NVIDIA (NVDA), Netflix (NFLX) and Visa (V). Company Calendar Last Earnings8/04/2025Today8/09/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED INSTRUMENTS Sub-IndustryMedical Equipment Current SymbolNASDAQ:CVRX CIK1235912 Webwww.cvrx.com Phone763-416-2840Fax763-416-2841Employees160Year FoundedN/APrice Target and Rating Average Price Target for CVRx$14.00 High Price Target$22.00 Low Price Target$7.00 Potential Upside/Downside+93.4%Consensus RatingModerate Buy Rating Score (0-4)2.86 Research Coverage7 Analysts Profitability EPS (Trailing Twelve Months)($2.10) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$59.97 million Net Margins-95.61% Pretax Margin-95.67% Return on Equity-79.31% Return on Assets-40.96% Debt Debt-to-Equity Ratio0.85 Current Ratio11.99 Quick Ratio13.45 Sales & Book Value Annual Sales$51.29 million Price / Sales3.69 Cash FlowN/A Price / Cash FlowN/A Book Value$2.22 per share Price / Book3.26Miscellaneous Outstanding Shares26,150,000Free Float22,517,000Market Cap$189.33 million OptionableOptionable Beta1.27 The Best Nuclear Energy Stocks to BuyNuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.Get This Free Report This page (NASDAQ:CVRX) was last updated on 8/9/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCrypto bros: Meet your replacementLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CVRx, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CVRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.